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 Materials and methods: Vibrational spectroscopy 
techniques, Fourier Transform Infrared (FTIR) Spectroscopy and 
Raman Spectroscopy (RS) have been applied and helped to 
determine the secondary structure and possible interactions and 
modifications of complex protein molecules, as well as protein-
ligand complexes.  
FT-IR spectroscopy measurements were conducted on 
PARAGON 1000 (Perkin Elmer) spectrophotometer in the spectral 
range 2000–500 cm-1 and the plates were scanned three times to 
minimize the influence of spotting variance. After spectral 
acquisition, data manipulation was performed with the Grams_32 
software (Thermo Scientific). 
The room temperature Raman spectra (2000–400 cm–1) were 
recorded on micro-Raman multichannel spectrometer Horiba 
JobinYvon LabRam 300 Infinity. The Raman effect was obtained 
using 632.8 nm line from a He:Ne laser. An Olympus MPlanN 
confocal microscope with ×100 objective for magnification was 
selected. The spectral resolution was set to 4 cm–1. The 
acquisition time and the accumulation number were set to 10 s 
and 10 scans, respectively. 
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CONCLUSION 
 
The approach presented here has significant potential for analyzing the structure, stability and possible toxicity of 
biotherapeutics as well as any other biological molecules which are used as therapeutic/diagnostic agents.  
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Fig. 2: Raman and ATR-IR spectra of rituximab and 
three types of experimental complexes 
 Background: Understanding the behaviour and function of biomolecules at the molecular level is 
the key to the discovery and development of new drugs, as well as diagnostic techniques. The characterization 
of biological drugs, where therapeutic monoclonal antibodies (mAbs) are placed, poses many challenges 
compared to those of low-molecular mass drugs because of their inherent complexity due to their protein nature. 
Achievements in this field of science have changed the way that drugs are being designed and developed 
nowadays.  
Fig. 1:  Diagram of preparation of formulations of monoclonal antibody 
preparations 
Results: Based on the frequencies assigned for amide bands, the investigated formulations contain the highest 
percentage of β-sheet conformation (antiparallel and parallel), followed by α-helices in the structure. In the 
experimental IR (in the region 2000-500 cm-1) and Raman spectra (2000–400 cm-1 region) we observed retaining of 
native structure of the antibody and modified antibody and no obvious aggregation in the formulations. 
Our investigation has demonstrated the use of these tools to understand protein-ligand interactions in important 
immune-complexes with previously no available structural information.  
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